Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Clinical Chemistry Views and Policy on Preprints.

Rifai N, Annesley TM, Boyd JC.

Clin Chem. 2018 Apr 24. pii: clinchem.2018.290445. doi: 10.1373/clinchem.2018.290445. [Epub ahead of print] No abstract available.

PMID:
29691223
2.

da Vinci's Spirals.

Annesley TM.

Clin Chem. 2017 Apr;63(4):931-933. doi: 10.1373/clinchem.2016.269001. No abstract available.

3.

Mollusks and Medicine.

Annesley TM.

Clin Chem. 2017 Feb;63(2):624-626. doi: 10.1373/clinchem.2016.267278. No abstract available.

4.

Clinical Mass Spectrometry-Achieving Prominence in Laboratory Medicine.

Annesley TM, Cooks RG, Herold DA, Hoofnagle AN.

Clin Chem. 2016 Jan;62(1):1-3. doi: 10.1373/clinchem.2015.251272. No abstract available.

5.

The P value: probable does not mean practical.

Annesley TM, Boyd JC.

Clin Chem. 2014 Jul;60(7):1021-3. No abstract available.

6.

To P or not to P: that is the question.

Boyd JC, Annesley TM.

Clin Chem. 2014 Jul;60(7):909-10. doi: 10.1373/clinchem.2014.226282. Epub 2014 May 14. No abstract available.

7.

Standardization of LC-MS for therapeutic drug monitoring of tacrolimus.

Annesley TM, McKeown DA, Holt DW, Mussell C, Champarnaud E, Harter L, Calton LJ, Mason DS.

Clin Chem. 2013 Nov;59(11):1630-7. doi: 10.1373/clinchem.2013.209114. Epub 2013 Jul 31.

8.

Writing an effective manuscript review: The 6 "Be's" to success.

Annesley TM.

Clin Chem. 2013 Jul;59(7):1028-35. doi: 10.1373/clinchem.2013.208280. Epub 2013 Jun 5. No abstract available.

9.

FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories?

Scott MG, Ashwood ER, Annesley TM, Leonard DG, Burgess MC.

Clin Chem. 2013 Jul;59(7):1017-22. doi: 10.1373/clinchem.2013.204958. Epub 2013 Mar 27. No abstract available.

10.

Now you be the judge.

Annesley TM.

Clin Chem. 2012 Nov;58(11):1520-6. doi: 10.1373/clinchem.2012.195529. Epub 2012 Oct 15. No abstract available.

11.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Clin Chem Lab Med. 2012 Mar;50(3):411-3. doi: 10.1515/cclm-2011-0904. No abstract available.

PMID:
22505546
12.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A.

Transfusion. 2012 Jun;52(6):e17-9. doi: 10.1111/j.1537-2995.2012.03620.x. Epub 2012 Mar 27. No abstract available.

PMID:
22452379
13.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Am J Hematol. 2012 Apr;87(4):347-8. doi: 10.1002/ajh.23121. No abstract available.

14.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Scand J Clin Lab Invest. 2012 Apr;72(2):89-91. doi: 10.3109/00365513.2011.654052. Epub 2012 Feb 17. No abstract available.

15.

Seven reasons not to be a peer reviewer--and why these reasons are wrong.

Annesley TM.

Clin Chem. 2012 Apr;58(4):677-9. doi: 10.1373/clinchem.2012.182618. Epub 2012 Feb 9. No abstract available.

16.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Clin Chem. 2012 Mar;58(3):483-5. doi: 10.1373/clinchem.2011.178426. Epub 2012 Feb 1. No abstract available.

17.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Joris Delanghe.

Clin Biochem. 2012 Feb;45(3):185-6. doi: 10.1016/j.clinbiochem.2011.12.011. No abstract available.

PMID:
22297270
18.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Statement by the Consortium of Laboratory Medicine Journal Editors.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Ann Clin Biochem. 2012 Mar;49(Pt 2):105-7. doi: 10.1258/acb.2011.201201. Epub 2012 Feb 1. No abstract available.

PMID:
22296778
19.

Sinusitis or something worse?

Fisher-Hubbard AO, Annesley TM, Warren J.

Clin Chem. 2012 Feb;58(2):477-8. doi: 10.1373/clinchem.2011.172700. No abstract available.

20.

An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.

Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, Ness PM, Plebani M, Wick MR, Wu A, Delanghe J.

Clin Chim Acta. 2012 Apr 11;413(7-8):653-5. doi: 10.1016/j.cca.2012.01.009. Epub 2012 Jan 13. No abstract available.

PMID:
22261017
21.

Is leadership a noun or verb?

Annesley TM, Hernandez JS, Morgan A, Pescovitz O, Wright I.

Clin Chem. 2012 Apr;58(4):667-71. doi: 10.1373/clinchem.2011.165639. Epub 2011 Dec 15. No abstract available.

22.

Passing the paternité test.

Annesley TM.

Clin Chem. 2011 Sep;57(9):1239-41. doi: 10.1373/clinchem.2011.170738. Epub 2011 Jul 22. No abstract available.

23.

Clinical chemistry trainee council: a new journal initiative.

Rifai N, Boyd JC, Annesley TM.

Clin Chem. 2011 Jul;57(7):935. doi: 10.1373/clinchem.2011.167023. Epub 2011 May 16. No abstract available.

24.

How to write a rave review.

Derish PA, Annesley TM.

Clin Chem. 2011 Mar;57(3):388-91. doi: 10.1373/clinchem.2010.160622. No abstract available.

25.

Top 10 tips for responding to reviewer and editor comments.

Annesley TM.

Clin Chem. 2011 Apr;57(4):551-4. doi: 10.1373/clinchem.2011.162388. Epub 2011 Jan 31. No abstract available.

26.

Giving credit: citations and references.

Annesley TM.

Clin Chem. 2011 Jan;57(1):14-7. doi: 10.1373/clinchem.2010.158048. Epub 2010 Nov 10. No abstract available.

27.

The discussion section: your closing argument.

Annesley TM.

Clin Chem. 2010 Nov;56(11):1671-4. doi: 10.1373/clinchem.2010.155358. Epub 2010 Sep 10. No abstract available.

28.

Bring your best to the table.

Annesley TM.

Clin Chem. 2010 Oct;56(10):1528-34. doi: 10.1373/clinchem.2010.153502. Epub 2010 Aug 11. No abstract available.

29.

Bars and pies make better desserts than figures.

Annesley TM.

Clin Chem. 2010 Sep;56(9):1394-400. doi: 10.1373/clinchem.2010.152298. Epub 2010 Jul 27. No abstract available.

30.

If an IRDAM journal is what you choose, then sequential results are what you use.

Derish PA, Annesley TM.

Clin Chem. 2010 Aug;56(8):1226-8. doi: 10.1373/clinchem.2010.150961. Epub 2010 Jul 7. No abstract available.

31.

Put your best figure forward: line graphs and scattergrams.

Annesley TM.

Clin Chem. 2010 Aug;56(8):1229-33. doi: 10.1373/clinchem.2010.150060. Epub 2010 Jun 15. No abstract available.

32.

Show your cards: the results section and the poker game.

Annesley TM.

Clin Chem. 2010 Jul;56(7):1066-70. doi: 10.1373/clinchem.2010.148148. Epub 2010 May 20. No abstract available.

33.

Who, what, when, where, how, and why: the ingredients in the recipe for a successful Methods section.

Annesley TM.

Clin Chem. 2010 Jun;56(6):897-901. doi: 10.1373/clinchem.2010.146589. Epub 2010 Apr 8. No abstract available.

34.

"It was a cold and rainy night": set the scene with a good introduction.

Annesley TM.

Clin Chem. 2010 May;56(5):708-13. doi: 10.1373/clinchem.2010.143628. Epub 2010 Mar 5. No abstract available.

35.

The abstract and the elevator talk: a tale of two summaries.

Annesley TM.

Clin Chem. 2010 Apr;56(4):521-4. doi: 10.1373/clinchem.2009.142026. Epub 2010 Feb 25. No abstract available.

36.

It's about the journey, Not the destination: The birth of radioimmunoassay. 1960.

Annesley TM.

Clin Chem. 2010 Apr;56(4):671-2. doi: 10.1373/clinchem.2010.142950. Epub 2010 Jan 28. No abstract available.

37.

The title says it all.

Annesley TM.

Clin Chem. 2010 Mar;56(3):357-60. doi: 10.1373/clinchem.2009.141523. Epub 2009 Dec 31. No abstract available.

38.

Preparation of manuscripts for publication: improving your chances for success.

Boyd JC, Rifai N, Annesley TM.

Clin Chem. 2009 Jul;55(7):1259-64. doi: 10.1373/clinchem.2009.129916. Epub 2009 May 21. No abstract available.

39.

Ultraperformance liquid chromatography-tandem mass spectrometry assay for iohexol in human serum.

Annesley TM, Clayton LT.

Clin Chem. 2009 Jun;55(6):1196-202. doi: 10.1373/clinchem.2008.121533. Epub 2009 Apr 9.

40.

Publication ethics: clinical chemistry editorial standards.

Annesley TM, Boyd JC, Rifai N.

Clin Chem. 2009 Jan;55(1):1-4. doi: 10.1373/clinchem.2008.120055. Epub 2008 Nov 21. No abstract available.

41.

Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry.

Annesley TM.

Clin Chem. 2007 Oct;53(10):1827-34. Epub 2007 Aug 16.

42.
43.

Application of commercial calibrators for the analysis of immunosuppressant drugs in whole blood.

Annesley TM.

Clin Chem. 2005 Feb;51(2):457-60. Epub 2004 Nov 24. No abstract available.

44.

Simple extraction protocol for analysis of immunosuppressant drugs in whole blood.

Annesley TM, Clayton L.

Clin Chem. 2004 Oct;50(10):1845-8. Epub 2004 Aug 12. No abstract available.

45.

Ion suppression in mass spectrometry.

Annesley TM.

Clin Chem. 2003 Jul;49(7):1041-4. Review.

46.

Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays.

McMillin GA, Owen WE, Lambert TL, De BK, Frank EL, Bach PR, Annesley TM, Roberts WL.

Clin Chem. 2002 Sep;48(9):1580-4. No abstract available.

47.

Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer.

Frank EL, Schwarz EL, Juenke J, Annesley TM, Roberts WL.

Am J Clin Pathol. 2002 Jul;118(1):124-31.

PMID:
12109846
48.

Glucuronidation of prodrug reactive site: isolation and characterization of oxymethylglucuronide metabolite of fosphenytoin.

Annesley TM, Kurzyniec S, Nordblom GD, Buchanan N, Pool W, Reily M, Talaat R, Roberts WL.

Clin Chem. 2001 May;47(5):910-8.

49.

Performance characteristics of four free phenytoin immunoassays.

Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP.

Ther Drug Monit. 2001 Apr;23(2):148-54.

PMID:
11294515
50.

National center for infectious diseases (NCID). URL: www.cdc. gov/ncidod/

Annesley TM.

Clin Chem. 2000 May;46(5):739. No abstract available.

Supplemental Content

Loading ...
Support Center